Related Experiment Video
Updated: Apr 21, 2026

04:09
Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
Published on: September 20, 2024
1.3K
Minimally invasive thyroid nodulectomy reduces post-operative hypothyroidism when compared with thyroid lobectomy
Leba M Sarkis1, Olov Norlen1, Mark Sywak1
1Endocrine Surgical Unit, The University of Sydney, Sydney, New South Wales, Australia.
ANZ Journal of Surgery
|November 14, 2014
Summary
Minimally invasive nodule excision significantly reduces post-operative hypothyroidism compared to thyroid lobectomy. This safer approach preserves thyroid mass and should be considered for select patients.
Area of Science:
- Endocrinology
- Surgical Oncology
- Thyroid Surgery
Background:
- Traditional thyroid nodule surgery (lobectomy) often leads to lifelong hypothyroidism.
- Newer techniques using thermal sealing devices allow for safer local nodule excision and thyroid mass preservation.
Purpose of the Study:
- To evaluate if local nodule excision reduces post-operative hypothyroidism rates compared to lobectomy.
- To assess the safety and efficacy of minimally invasive nodulectomy.
Main Methods:
- Retrospective cohort study of 351 patients (Jan 2010 - Dec 2012).
- Classified procedures: open lobectomy, minimally invasive lobectomy, and minimally invasive nodulectomy.
- Defined subclinical hypothyroidism (TSH >4.5 mIU/L) and clinical hypothyroidism (elevated TSH with symptoms requiring thyroxine).
Main Results:
- Post-operative hypothyroidism rates were similar for open (22.1%) and minimally invasive lobectomy (22.1%).
- Minimally invasive nodulectomy resulted in significantly lower hypothyroidism rates (5.3%) compared to lobectomy overall (22.1%, P < 0.01).
- No significant differences in post-operative complications were observed across all groups.
Conclusions:
- Minimally invasive local nodule excision is a safe procedure.
- This technique offers a significant reduction in post-operative hypothyroidism.
- Consider minimally invasive nodulectomy for appropriately selected thyroid nodule patients.
Related Concept Videos
Hypothyroidism II: Pathophysiology
7
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
7
Hyperthyroidism II: Pathophysiology
7
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
7
The Thyroid Gland
9.2K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
9.2K
Hyperthyroidism I: Introduction
6
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
6

